The Institute of Biomedical Ethics and History of Medicine (IBME) has been redesignated as a World Health Organization (WHO) Collaborating Center for Bioethics. The partnership between IBME and the WHO has been ongoing for the last twelve years and the redesignation extends this collaboration for another four years.
IBME and WHO have agreed on a work plan that includes the continuation of the activities of the Forum for Global Health Ethics, a collaborative community of researchers, students, practitioners, policy makers and the public at large. The Forum has two main activities. It organizes international webinars in which experts exchange ideas on pressing topics in global health, and it is developing a website for discussing cases in global health that pose ethical challenges.
The work plan with WHO also includes the provision of ethical guidance in the restoration of health services after humanitarian crises, and in the conduct and review of Health Policy and System Research (HPSR), mainly in implementation research. Moreover, the plan considers continuing the collaboration in the fields of ethics and public health emergency preparedness and response. In this context, an IBME team recently conducted a study for the WHO on the challenges to global access to equitable COVID-19 vaccines through the COVAX facility.
To further strengthen its participation in the Global Network of WHO Collaborating Centers for Bioethics, IBME has offered to host one of the yearly meetings of the network in the next few years.